C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 453/02 (2006.01) A61K 31/44 (2006.01) C07D 487/08 (2006.01)
Patent
CA 2294990
Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia) are treated by administering an endo or exo form of a 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, a I-aza-2-(3-pyridyl)bicyclo[2.2.2] octane, a 1-aza-2-(3- pyridyl)bicyclo[3.2.2]nonane, a 1-aza-7-(3-pyridyl) bicyclo[2.2.1]heptane, a 1-aza-3-(3-pyridyl)bicyclo[3.2.2]nonane, or a 1-aza-7-(3- pyridyl)bicyclo[3.2.2]nonane.
La présente invention concerne un traitement destiné à des patients susceptibles de souffrir ou souffrant effectivement de troubles tels que les troubles du système nerveux central, qui sont caractérisés par une altération de la libération normale d'un neurotransmetteur telle que la libération de dopamine (par exemple le parkinsonisme, la maladie de Parkinson, la maladie de Gilles de la Tourette, le déficit de la capacité d'attention ou la schizophrénie). Ce traitement consiste en l'administration de la forme <u>endo</u> ou <u>exo</u> d'un 1-aza-2-(3-pyridyl)bicyclo[2.2.1]heptane, d'un 1-aza-2-(3-pyridyl)bicyclo[2.2.2]octane, d'un 1-aza-2-(3-pyridyl)bicyclo[3.2.2]nonane, d'un 1-aza-7-(3-pyridyl)bicyclo[2.2.1]heptane, d'un 1-aza-3-(3-pyridyl)bicyclo[3.2.2]octane, ou d'un 1-aza-7-(3-pyridyl)bicyclo[3.2.2]nonane.
Bencherif Merouane
Bhatti Balwinder Singh
Caldwell William Scott
Crooks Peter Anthony
Deo Niranjan Madhukar
R.j. Reynolds Tobacco Company
Robic
Targacept Inc.
University Of Kentucky Research Foundation
LandOfFree
Pharmaceutical compositions and methods for effecting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and methods for effecting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods for effecting... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1497003